Skip Navigation



Human Molecular Genetics Advance Access published online on November 12, 2003

Human Molecular Genetics, doi:10.1093/hmg/ddh003
© 2003 by Oxford University Press
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/1/7    most recent
ddh003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cogram, P.
Right arrow Articles by Copp, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cogram, P.
Right arrow Articles by Copp, A. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

©2003 Oxford University Press

Article

Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol

Patricia Cogram 1, Andrew Hynes 2, Louisa P.E. Dunlevy 1, Nicholas D.E. Greene 1, and Andrew J. Copp 3*

1 Neural Development Unit, Institute of Child Health, University College London, London, WC1N 1EH, UK
2 Neural Development Unit, Institute of Child Health, University College London, London, WC1N 1EH, UK; Etiologics Limited, Harwell, Oxfordshire, OX11 0RD, UK
3 Neural Development Unit, Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK

* To whom correspondence should be addressed. E-mail: a.copp{at}ich.ucl.ac.uk.


   Abstract

A proportion of neural tube defects (NTDs) can be prevented by maternal folic acid supplementation, although some cases are unresponsive. The curly tail mutant mouse provides a model of folate-resistant NTDs, in which defects can be prevented by inositol therapy in early pregnancy. Hence, inositol represents a possible novel adjunct therapy to prevent human NTDs. The present study investigated the molecular mechanism by which inositol prevents mouse NTDs . Activation of protein kinase C (PKC) is known to be essential, and we examined neurulation-stage embryos for PKC expression and applied PKC inhibitors to curly tail embryos developing in culture. Although all known PKC isoforms were detected in the closing neural tube, use of chemical PKC inhibitors identified a requirement particularly for ‘conventional’ PKC isoforms. Peptide inhibitors offer selective inhibition of individual PKCs, and we demonstrated isoform-specific inhibition of PKC in embryonic cell cultures. Application of peptide inhibitors to neurulation-stage embryos revealed an absolute dependence on the activity of PKC{beta}I and {gamma} for prevention of NTDs by inositol, and partial dependence on PKC{zeta}, whereas other PKCs ({alpha}, {beta}II, {delta}, and {varepsilon}) were dispensable. To investigate the cellular action of inositol and PKCs in NTD prevention, we examined cell proliferation in curly tail embryos. Defective proliferation of hindgut cells is a key component of the pathogenic sequence leading to NTDs in curly tail. Hindgut cell proliferation was stimulated specifically by inositol, an effect that required activation of PKC{beta}I. Our findings reveal an essential role of specific PKC isoforms in mediating the prevention of mouse NTDs by inositol.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
P. Gustavsson, N. D.E. Greene, D. Lad, E. Pauws, S. C.P. de Castro, P. Stanier, and A. J. Copp
Increased expression of Grainyhead-like-3 rescues spina bifida in a folate-resistant mouse model
Hum. Mol. Genet., November 1, 2007; 16(21): 2640 - 2646.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
V. Aaltonen, J. Koivunen, M. Laato, and J. Peltonen
Heterogeneity of Cellular Proliferation within Transitional Cell Carcinoma: Correlation of Protein Kinase C Alpha/betaI Expression and Activity
J. Histochem. Cytochem., July 1, 2006; 54(7): 795 - 806.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.